Tag: CD30

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to CD30

EPS for Theratechnologies Inc. (TH) Expected At $0.02

Added to Collection on: 2019-01-05 12:41:15

Tags for this article:

Biology
Cell biology
Biotechnology
Cannabis classification in the United Kingdom
Seattle Genetics
TSE
Brentuximab vedotin
Tesamorelin
CD30
Monomethyl auristatin E

Click the tags to see associated articles and topics

View Article Details
Emera Incorporated (EMA) EPS Estimated At $0.63 as of February, 8

Added to Collection on: 2019-01-31 23:06:22

Tags for this article:

Economy of Canada
EMA
Emera
Brentuximab vedotin
CD30
Emera Incorporated

Click the tags to see associated articles and topics

View Article Details
Peripheral T-cell Lymphoma Market to exhibit a CAGR of 9.46% during the forecast period of 2020 ...

Added to Collection on: 2021-02-02 16:52:30

Tags for this article:

Clinical medicine
Medical specialties
Drugs
Orphan drugs
T cells
Antineoplastic drugs
Peripheral T-cell lymphoma not otherwise specified
Seagen
Brentuximab vedotin
CD30
T-cell lymphoma
Romidepsin
Germany
Italy
France
Japan
United States
United Kingdom
Spain

Click the tags to see associated articles and topics

View Article Details
A Diagnosis of Lymphoma Has Changed My Life - The ASCO Post

Added to Collection on: 2024-11-08 21:00:16

Tags for this article:

Lymphoma
Hematology
Oncology
Brentuximab vedotin
CD30
Hodgkin lymphoma
Chemotherapy
Monomethyl auristatin E
Hematopoietic stem cell transplantation
Cancer
Radiation therapy
Seagen
Ethan Zohn

Click the tags to see associated articles and topics

View Article Details
Natural killer cells, a rising alternative to CAR-T cell therapy | PharmaVoice

Added to Collection on: 2025-01-27 13:09:30

Tags for this article:

Immune system
Biotechnology
Lymphoma
Cell biology
Lymphocytes
Natural killer cell
Rituximab
CAR T cell
CD30
Cell therapy
NK-92
Cancer immunotherapy
Fred Aslan

Click the tags to see associated articles and topics

View Article Details
FDA Approves Pfizer Combination Regimen for Treating R/R Diffuse Large B-Cell Lymphoma

Added to Collection on: 2025-02-14 16:17:18

Tags for this article:

Lymphoma
Non-Hodgkin lymphoma
Antibody-drug conjugates
Brentuximab vedotin
Antibody-drug conjugate
Seagen
Monomethyl auristatin E
Diffuse large B-cell lymphoma
CD30
Indolent lymphoma
Pfizer
Lenalidomide
Rituximab

Click the tags to see associated articles and topics

View Article Details
Book a Demo